Back to search

Belgium· BE-AMP-SAM662618-00

Voydeya 50 mg - 100 mg

A danicopan product containing danicopan, registered in Belgium by Alexion Europe. The same ATC class is registered in 14 of our 19 countries.

ATC L04AJ09

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedVoydeya 50 mg - 100 mgATCL04AJ09REGISTER NO.BE-AMP-SAM662618-00PACKS LISTED0CHECKEDSeptember 26, 2026

Where it is registered

Danicopan is registered in 14 of 19 countries.

Countries holding a registration under ATC L04AJ09 (danicopan), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 8 of them publish a price we can compare per daily dose

Danicopan · ATC L04AJ09

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of danicopan costs, country by country.

Normalised to the WHO defined daily dose (0.45 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Danicopan · price per daily dose (0.45 g)

USD · FX 28 Sept 2026

  • FR France$0.41
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Danicopan
Manufacturer
Alexion Europe
Country
Belgium (BE)
ATC code
L04AJ09
ATC class
Danicopan
Defined daily dose
0.45 g, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d558975f-1757-452e-a9dd-32b4cb57697c
GET /v1/drugs/d558975f-1757-452e-a9dd-32b4cb57697c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Voydeya 50 mg - 100 mg",
  "name_fr": "Voydeya 50 mg - 100 mg",
  "name_nl": "Voydeya 50 mg - 100 mg",
  "amp_code": "SAM662618-00",
  "strengths": [
    "100.0000",
    "100.0000",
    "115.0000",
    "50.0000",
    "50.0000",
    "57.5000"
  ],
  "pack_count": 2,
  "substances": [
    "Danicopan",
    "Lactose Monohydrate",
    "Sodium Laurilsulfate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Danicopan",
  "authorisation_numbers": [
    "EU/1/24/1792/002",
    "EU/1/24/1792/001"
  ]
}

See everything about danicopan.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.